Fertility supplement contains nutrients, such as folic acid, fish oil, selenium, vitamin E, vitamin D, and others to enhance the fertility of the individuals. Surge in the prevalence of infertility globally and rising rates of obesity are the key drivers boosting the growth of the market. For instance, according to the World Health Organization, in 2021, there were around 48 million couples, and 186 million individuals suffering from infertility disease globally. Apart from this, an increase in disposable income and the high adoption of a sedentary lifestyle is also having a positive impact on the market during the forecast period.
The Fertility Supplement Market is expected to grow at a steady rate of around 7.8% during the forecast period (2022-2028) owing to an increase in incidences of infertility cases and the emerging trend of delayed pregnancies among women. Apart from this, the surge in the prevalence of smoking, diabetes, and other lifestyle-related disorders is driving the growth of the market. Furthermore, there is growing adoption of herbal medicines (botanicals) owing to the increasing concerns about the harmful impacts associated with traditional pharmaceutical drugs is poised to generate new opportunities for fertility supplement manufacturers, leading to the growth of the fertility supplement market. However, a lack of awareness among the population of low-income economies is anticipated to restrain the growth of the global fertility supplements market.
Access a sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=30030
Based on ingredient, the market is segmented into natural and synthetic/blend of natural & synthetic. The synthetic segment is expected to grow with high CAGR rates during the forecast period. Several factors such as the high usage of synthetic ingredients including selenium, folic acid, vitamin B6, COQ10, and zinc due to their easy availability and increased demand is a key factor driving the growth of the market during the forecast period.
Based on product, the market is categorized into capsules, tablets, soft gels, powder, and liquids. The capsule segment held the dominant share of the market due to wide availability of the products. Moreover, the companies are rapidly launching new products, which is another factor propelling the market’s growth. For instance, in 2022, Ovaterra launched two new prenatal vitamin supplements, Advanced Prenatal and Advanced Prep 35-39. They are prenatal capsules formulated with the full recommended daily value of choline for pregnant and nursing women.
Based on the end-user, the fertility supplement market is segmented into men and women. Women held the maximum share in the global market due to an increase in fertility issues among married infertile women aged 40 to 44, followed by women aged 35 to 39. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2021, about 19% of women between 15-49 years of age with no prior births suffer from infertility issues. Initiatives by the government and non-profit organizations to provide advice and medical assistance have helped raise awareness, resulting in opportunities for product manufacturers in the market.
Based on the distribution, the market is classified as OTC and prescribed. OTC held the majority of the share in the global market due to its cost-effectiveness and convenience of direct purchase. Apart from this, the growing trend of self-medication among individuals is also driving the growth of the segment during the forecast period.
For a detailed analysis of the Global Fertility Supplement Market browse through– https://univdatos.com/report/fertility-supplement-market/
For a better understanding of the market adoption of the fertility supplement industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period due to growing nutritional knowledge in India and China. Other factors, such as rising disposable income, increasing healthcare expenditure, and a surge in fertility supplement manufacturers are also driving the growth of the market in the Asia-Pacific region. In addition to this, the continuous expansion of the retail market in emerging economies of the region to promote investments of key manufacturers is anticipated to augment the market growth in the region.
Some of the major players operating in the market include Fairhaven Health; Coast Science; Lenus Pharma GesmbH; Bionova; Vitabiotics Ltd.; Orthomol; Exeltis USA, Inc.; The Bird and Be Co. Inc.; VH Nutrition LLC, and TTK HealthCare Ltd.
Global Fertility Supplement Market Segmentation
Market Insight, by Ingredient
• Synthetic/ Blend of Natural & Synthetic
Market Insight, by Product
- Soft Gels
Market Insight, by End-User
Market Insight, by Distribution
Market Insight, by Region
- North America US
- Rest of North America
- United Kingdom
- Rest of Europe
- Rest of Asia-Pacific
- Rest of the World
Top Company Profiles
- Fairhaven Health
- Coast Science
- LENUS Pharma GesmbH
- VH Nutrition LLC
- TTK HealthCare Ltd
- The Bird and Be Co. Inc.
- Exeltis USA, Inc.